Position in ABVX
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$1,674,704
-$395,050 QoQ
Shares Held
15,040
-2.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANQUE PICTET & CIE SA holds $213,407,213 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
2,699,402 | $189,039,122 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,496 | $11,671,168 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
44,736 | $2,600,503 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
43,332 | $2,325,628 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,713 | $2,315,204 | |
| 6 | IMVT |
Immunovant, Inc.
|
57,190 | $2,203,530 | |
| 7 | BNTX |
BioNTech SE
|
17,705 | $1,647,450 | |
| 8 | AVIR |
Atea Pharmaceuticals, Inc.
|
345,077 | $1,604,608 |
All Filings in ABVX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,674,704 | 15,040 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $2,069,754 | 15,348 | Shares | Sole | 2026-01-16 | |
| No filing history on record for this holder in this stock. | ||||||